Cardiogenic Shock – SOLACI-SOCIME 2022@SCAI Session

✔️ Cardiogenic Shock – SOLACI-SOCIME 2022@SCAI Session

✔️ Video del SOLACI-SOCIME 2022

👨‍🏫 Contents:

00:15 – Interactive Case presentation: STEMI with Multivessel Disease and Cardiogenic Shock. Panel discussion Fellow from SOLACI – Dr. Daniel Zazueta (MEX)
10:03 – Classification and Prognosis: The SCAI SHOCK Consensus – Dr. Hector Tamez (USA)
21:42 – Treatment of STEMI with Cardiogenic Shock: PCI and MCS Selection and Timing – Dr. Mauricio Cohen (USA)
39:20 – Treatment Consideration in Women: Results from the RECOVER III Study – Dra. Alexandra Lansky (USA)
51:40 – Treatment of STEMI with Cardiogenic Shock: When to escalate to ECMO – Dr. Gregory Serrao (USA)


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Advances in Structural Intervention – SOLACI-SOCIME 2022

✔️ Advances in Structural Intervention - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - Palabras de Bienvenida - Dr. Guering Eid-Lidt (MEX)...

Endovascular Treatment of Femoropopliteal Segment – SOLACI-SOCIME 2022

✔️ Endovascular Treatment of Femoropopliteal Segment - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - How Palabras de bienvenida - Dr. Luis Virgen...

Pulmonary Valve – SOLACI-SOCIME 2022

✔️ Pulmonary Valve - SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Scientific Sessions 👨‍🏫 Contents: 00:10 - How to select the type of THV in pulmonary valve...

Complex PCI: Distal Left Main Coronary Artery – SOLACI-SOCIME 2022

✔️ Complex PCI: Distal Left Main Coronary Artery - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session.  👨‍🏫 Contents: 00:13 - Welcoming words - Dr. Álvaro...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...